Literature DB >> 18256031

Identification of an intronic splicing enhancer essential for the inclusion of FGFR2 exon IIIc.

Puneet Seth1, Heather B Miller, Erika L Lasda, James L Pearson, Mariano A Garcia-Blanco.   

Abstract

The ligand specificity of fibroblast growth factor receptor 2 (FGFR2) is determined by the alternative splicing of exons 8 (IIIb) or 9 (IIIc). Exon IIIb is included in epithelial cells, whereas exon IIIc is included in mesenchymal cells. Although a number of cis elements and trans factors have been identified that play a role in exon IIIb inclusion in epithelium, little is known about the activation of exon IIIc in mesenchyme. We report here the identification of a splicing enhancer required for IIIc inclusion. This 24-nucleotide (nt) downstream intronic splicing enhancer (DISE) is located within intron 9 immediately downstream of exon IIIc. DISE was able to activate the inclusion of heterologous exons rat FGFR2 IIIb and human beta-globin exon 2 in cell lines from different tissues and species and also in HeLa cell nuclear extracts in vitro. DISE was capable of replacing the intronic activator sequence 1 (IAS1), a known IIIb splicing enhancer and vice versa. This fact, together with the requirement for DISE to be close to the 5'-splice site and the ability of DISE to promote binding of U1 snRNP, suggested that IAS1 and DISE belong to the same class of cis-acting elements.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18256031      PMCID: PMC2442303          DOI: 10.1074/jbc.M800087200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  TIA-1 and TIAR activate splicing of alternative exons with weak 5' splice sites followed by a U-rich stretch on their own pre-mRNAs.

Authors:  C Le Guiner; F Lejeune; D Galiana; L Kister; R Breathnach; J Stévenin; F Del Gatto-Konczak
Journal:  J Biol Chem       Date:  2001-08-20       Impact factor: 5.157

Review 2.  Co-transcriptional splicing of pre-messenger RNAs: considerations for the mechanism of alternative splicing.

Authors:  A C Goldstrohm; A L Greenleaf; M A Garcia-Blanco
Journal:  Gene       Date:  2001-10-17       Impact factor: 3.688

3.  The RNA-binding protein TIA-1 is a novel mammalian splicing regulator acting through intron sequences adjacent to a 5' splice site.

Authors:  F Del Gatto-Konczak; C F Bourgeois; C Le Guiner; L Kister; M C Gesnel; J Stévenin; R Breathnach
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

4.  A monomeric red fluorescent protein.

Authors:  Robert E Campbell; Oded Tour; Amy E Palmer; Paul A Steinbach; Geoffrey S Baird; David A Zacharias; Roger Y Tsien
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

5.  RNAi-mediated PTB depletion leads to enhanced exon definition.

Authors:  Eric J Wagner; Mariano A Garcia-Blanco
Journal:  Mol Cell       Date:  2002-10       Impact factor: 17.970

6.  Inhibition of msl-2 splicing by Sex-lethal reveals interaction between U2AF35 and the 3' splice site AG.

Authors:  L Merendino; S Guth; D Bilbao; C Martínez; J Valcárcel
Journal:  Nature       Date:  1999-12-16       Impact factor: 49.962

7.  Imaging the alternative silencing of FGFR2 exon IIIb in vivo.

Authors:  Vivian I Bonano; Sebastian Oltean; Robert M Brazas; Mariano A Garcia-Blanco
Journal:  RNA       Date:  2006-10-26       Impact factor: 4.942

8.  An intronic splicing silencer causes skipping of the IIIb exon of fibroblast growth factor receptor 2 through involvement of polypyrimidine tract binding protein.

Authors:  R P Carstens; E J Wagner; M A Garcia-Blanco
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

9.  TIA-1 or TIAR is required for DT40 cell viability.

Authors:  Caroline Le Guiner; Marie-Claude Gesnel; Richard Breathnach
Journal:  J Biol Chem       Date:  2003-01-17       Impact factor: 5.157

10.  Of urchins and men: evolution of an alternative splicing unit in fibroblast growth factor receptor genes.

Authors:  Neville Mistry; Whitney Harrington; Erika Lasda; Eric J Wagner; Mariano A Garcia-Blanco
Journal:  RNA       Date:  2003-02       Impact factor: 4.942

View more
  7 in total

1.  Silencing and transcriptional properties of the imprinted Airn ncRNA are independent of the endogenous promoter.

Authors:  Stefan H Stricker; Laura Steenpass; Florian M Pauler; Federica Santoro; Paulina A Latos; Ru Huang; Martha V Koerner; Mathew A Sloane; Katarzyna E Warczok; Denise P Barlow
Journal:  EMBO J       Date:  2008-11-13       Impact factor: 11.598

2.  Fox-2 protein regulates the alternative splicing of scleroderma-associated lysyl hydroxylase 2 messenger RNA.

Authors:  Puneet Seth; Heather N Yeowell
Journal:  Arthritis Rheum       Date:  2010-04

3.  Exon exchange approach to repair Duchenne dystrophin transcripts.

Authors:  Stéphanie Lorain; Cécile Peccate; Maëva Le Hir; Luis Garcia
Journal:  PLoS One       Date:  2010-05-28       Impact factor: 3.240

Review 4.  Fibroblast growth factor signalling: from development to cancer.

Authors:  Nicholas Turner; Richard Grose
Journal:  Nat Rev Cancer       Date:  2010-02       Impact factor: 60.716

5.  Human genetic variation recognizes functional elements in noncoding sequence.

Authors:  David Lomelin; Eric Jorgenson; Neil Risch
Journal:  Genome Res       Date:  2009-12-23       Impact factor: 9.043

6.  Spliceosome-Mediated Pre-mRNA trans-Splicing Can Repair CEP290 mRNA.

Authors:  Scott J Dooley; Devin S McDougald; Krishna J Fisher; Jeanette L Bennicelli; Lloyd G Mitchell; Jean Bennett
Journal:  Mol Ther Nucleic Acids       Date:  2018-06-27       Impact factor: 8.886

7.  Dunning rat prostate adenocarcinomas and alternative splicing reporters: powerful tools to study epithelial plasticity in prostate tumors in vivo.

Authors:  Sebastian Oltean; Phillip G Febbo; Mariano A Garcia-Blanco
Journal:  Clin Exp Metastasis       Date:  2008-06-04       Impact factor: 5.150

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.